(Q83305244)
Statements
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401 (English)
Per Malmström
Scandinavian Breast Group Trial 9401
Minna Tanner
Jorma Isola
Björn Erikstein
Pirkko Kellokumpu-Lehtinen
Nils Wilking
Jonas Nilsson